Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:OCUL News 6 December 2025 - 9 December 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

All figures and opinions reflect information available on December 9, 2025 and may change over time. This article is for informational purposes only and is not investment advice. OCUL Stock Today: A 52‑Week High After a Single Press Release Ocular Therapeutix, Inc. (NASDAQ: OCUL) has suddenly moved from sleepy mid-cap biotech to front-page ticker. On Monday, December 8, the stock closed at $16.11, up 28.1% on the day, after trading as high as $16.44 and setting a new 52‑week high. The prior close was $12.58, meaning the name has rallied sharply over just a few sessions.FinancialContent+1 Year to date, OCUL
9 December 2025
Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges

Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges

As of the close on Friday, December 5, 2025, Ocular Therapeutix, Inc. (NASDAQ: OCUL) finished regular trading at $12.58 per share, up about 1.2% on the day, with after‑hours quotes on some platforms briefly touching the $14 area. StockAnalysis+1 The move caps a strong week: on Thursday the stock jumped roughly 12.3% to around $12.87, well above its recent averages, as traders responded to a new regulatory strategy for its lead retina drug AXPAXLI and fresh analyst commentary. MarketBeat+1 At the same time, OCUL remains firmly in “story stock” biotech territory: still loss‑making, heavily dependent on its late‑stage pipeline, but
6 December 2025
···

Stock Market Today

Astera Labs (ALAB) stock closes near $170 after 19% jump as earnings week looms

8 February 2026
New York, Feb 7, 2026, 20:34 (EST) — Market closed. Astera Labs, Inc. shares surged 18.9% on Friday to close at $169.85, after ending the prior session at $142.82. The stock traded between $151.42 and $170.01, with about 7.3 million shares changing hands. (StockAnalysis) With U.S. markets shut for the weekend, the move leaves the Nasdaq-listed chip-connectivity firm in focus heading into Monday’s open. Attention now shifts to its quarterly report due next week, a key check on demand for parts that sit inside AI data centers. Astera Labs makes connectivity chips and software that help move data inside servers
Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

8 February 2026
Sungrow closed at 144.50 yuan, down 1.03%, after stating it has no plans in the commercial space sector. Mainland China trading resumes Monday, with Spring Festival closures set for Feb. 15–23. Major funds were net sellers of 5.46 billion yuan on Feb. 6. The Shenzhen-listed solar firm remains under scrutiny as investors await further filings before the holiday.
MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

8 February 2026
Monolithic Power Systems shares surged 6.4% to $1,229.82 Friday, hitting a new 52-week high after raising its dividend to $2.00 and forecasting first-quarter revenue of $770 million to $790 million. CEO Michael Hsing filed a Rule 144 notice for 3,082 shares. CFO Bernie Blegen will retire after the 2025 annual report, with Rob Dean named interim CFO. Fourth-quarter revenue rose 20.8% to $751.2 million.
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

8 February 2026
Microchip Technology shares fell 2.6% to $76.01 Friday after its outlook and analyst reactions disappointed some investors. The company reported fiscal Q3 net sales up 15.6% to $1.186 billion and guided March-quarter sales to $1.24–$1.28 billion. A global memory shortage has disrupted orders, and analysts remain split on recovery prospects. BlackRock disclosed a 10% stake as of Jan. 31.
Go toTop